Lincoln Pharmaceuticals Q3 FY24 Results Live: Profit Rises by 29.74% YoY
Lincoln Pharmaceuticals declared their Q3 FY24 results on 08 Feb, 2024. The topline increased by 9.48% & the profit increased by 29.74% YoY.
As compared to the previous quarter, the revenue declined by 6.11% and the profit increased by 1.4%. The Selling, general & administrative expenses rose by 6% q-o-q & increased by 12.78% Y-o-Y.
The operating income was down by 6.02% q-o-q & increased by 9.63% Y-o-Y. The EPS is ₹14 for Q3 FY24 which increased by 29.75% Y-o-Y.
Lincoln Pharmaceuticals has delivered 1.76% return in the last 1 week, 34.49% return in the last 6 months and 8% YTD return. Currently, Lincoln Pharmaceuticals has a market cap of ₹1318.46 Cr and 52wk high/low of ₹714.95 & ₹317 respectively.FAQsQuestion : What is the Q3 FY24 profit/Loss as per company?Ans : ₹28.04CrQuestion : What is Q3 FY24 revenue?Ans : ₹146.45Cr Stay updated on quarterly results with our results calendarMilestone Alert!
Livemint tops charts as the fastest growing news website in the world
